Mithat Gonen
Genetics · 2001–2022
A researcher in the Science corpus: 14 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 19 citations into it
- Statistics and Probability — 16 citations into it; #7,667 of 12,932 by trust here, #1,706 by citations
- Epidemiology — 8 citations into it
- Endocrinology, Diabetes and Metabolism — 7 citations into it
Whom Mithat Gonen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Mithat Gonen overall
- Patrick Royston
- Ewout W. Steyerberg
- Tapio Pahikkala
- Douglas G. Altman
- Andrew J. Vickers
- Antti Airola
- M. Pavlou
Papers from Mithat Gonen's perspective
Ordered by how strongly the researchers Mithat Gonen trusts endorse each paper. Same corpus, a different order for every researcher.
- What do we mean by validating a prognostic model? (Statistics in Medicine)
- Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
- Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. (American Journal of Epidemiology)
- Estimation of time‐dependent area under the ROC curve for long‐term risk prediction (Statistics in Medicine)
- Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. (Clinical Chemistry)
- Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
- Clinical Prediction Models—a Practical Approach to Development, Validation and Updating
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond (Statistics in Medicine)
- Survival Model Predictive Accuracy and ROC Curves (Biometrics)
- Why Most Discovered True Associations Are Inflated (Epidemiology)
Their papers
- Assessing the performance of prediction models: a framework for some traditional and novel measures (2010) — 4,522 citations
- Concordance probability and discriminatory power in proportional hazards regression (2005) — 721 citations
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia (2014) — 2,346 citations
- PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer (2022) — 1,021 citations
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia (2018) — 2,147 citations
- Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL) (2018) — 722 citations
- Nomograms in Oncology – More than Meets the Eye (2015) — 2,652 citations
- The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. (2011) — 890 citations
- Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System (2010) — 915 citations
- Actual 10-year survival after resection of colorectal liver metastases defines cure. (2007) — 1,136 citations
- Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma (2004) — 618 citations
- Influence of Transfusions on Perioperative and Long-Term Outcome in Patients Following Hepatic Resection for Colorectal Metastases (2003) — 598 citations
- Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade (2002) — 1,673 citations
- Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma (2001) — 1,324 citations